PECAM1 and neoplasm: Studies were completed by immunohistochemistry with the endothelial cell marker CD31 (also known as PECAM-1 or Platelet Endothelial Cell Adhesion Molecule-1), a transmembrane glycoprotein expressed by endothelial cells to assess the evolution of vascular density and vascular integrity in the tumor [30–32].